Bionano Genomics, Inc. Warrant
BNGOW
BNGOW was delisted on the 17th of August, 2023.
5 hedge funds and large institutions have $56K invested in Bionano Genomics, Inc. Warrant in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
67% more funds holding
Funds holding: 3 → 5 (+2)
47% less capital invested
Capital invested by funds: $105K → $56K (-$49K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$14.9K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.23K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$15.7K |
BNGOW Hedge Fund Activity: Q4 2019 in Review
5 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics, Inc. Warrant (BNGOW) for Q4 2019, worth a combined $56K — down 47% from $105K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BNGOW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $14.9K. The largest seller was Monashee Investment Management, cutting an estimated $15.7K.
- 5 institutional investors held Bionano Genomics, Inc. Warrant (BNGOW) as of Q4 2019, up from 3 in Q3 2019.
- Funds reported $56K of Bionano Genomics, Inc. Warrant stock for Q4 2019, down 47% quarter-over-quarter.
- 2 funds opened new Bionano Genomics, Inc. Warrant positions in Q4 2019 and 0 closed out, a net change of +2 holders.
- The largest Bionano Genomics, Inc. Warrant buyer in Q4 2019 was Susquehanna International Group, an estimated $14.9K added.
- The largest Bionano Genomics, Inc. Warrant seller in Q4 2019 was Monashee Investment Management, an estimated $15.7K sold.
Based on aggregated 13F filings for Q4 2019.